Toward the end of trading Thursday, the Dow traded down 0.20% to 34,745 while the NASDAQ fell 0.03% to 15,157.61. The S&P also fell, dropping 0.21% to 4,471.34.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 41,539,100 cases with around 666,620 deaths. India confirmed a total of at least 33,347,320 cases and 443,920 deaths, while Brazil reported over 21,034,610 COVID-19 cases with 588,590 deaths. In total, there were at least 226,445,290 cases of COVID-19 worldwide with more than 4,661,150 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Consumer discretionary shares gained 0.2% on Thursday. Meanwhile, top gainers in the sector included Tuesday Morning Corporation TUEM +undefined% (Get Free Alerts for TUEM), up 29% and Rush Street Interactive, Inc. RSI +undefined% (Get Free Alerts for RSI) up 10%.
In trading on Thursday, materials shares tumbled 1.1%.
Top Headline
US retail sales increased 0.7% in August of 2021, following a revised 1.8% decline in July. Analysts were expecting for a 0.8% decline in retail trade.
Equities Trading UP
Leap Therapeutics, Inc. LPTX +undefined% shares shot up 39% to $2.6750 after the company announced updated data from the first-line cohort of the DisTinGuish Phase 2a trial evaluating DKN-01 combined with BeiGene’s tislelizumab and chemotherapy in gastric or gastroesophageal junction cancer (G/GEJ).
Shares of Tuesday Morning Corporation TUEM +undefined% (Get Free Alerts for TUEM) got a boost, shooting 29% to $2.23 after a SEC filing showed CEO Fred Hand purchased 511,387 shares of the company's common stock at an average price of $1.76.
TMC the metals company Inc. TMC +undefined% shares were also up, gaining 18% to $11.78 amid increased retail investor interest in the stock on social media.
Equities Trading DOWN
Silverback Therapeutics, Inc. SBTX +23.26% shares tumbled 24% to $12.34. The company presented interim clinical results from a Phase 1/1b clinical study of SBT6050 as a monotherapy and in combination with Merck & Co's Keytruda in patients with advanced or metastatic HER2-expressing or amplified solid tumors.
Shares of Aerie Pharmaceuticals, Inc. AERI +20.92% were down 25% to $11.84 after the company announced topline results of its Phase 2b COMET-1 study evaluating AR-15512 (TRPM8 Agonist) ophthalmic solution for dry eye disease. The company said that the study failed to achieve statistical significance at pre-determined primary endpoints at Day 28.
MacroGenics, Inc. MGNX +23.72% was down, falling 26% to $20.46 as the company disclosed results from Cohort A Part 1 of the Phase 2/3 MAHOGANY clinical trial of margetuximab.
Commodities
In commodity news, oil traded down 0.3% to $72.41, while gold traded down 2.2% to $1,756.00.
Silver traded down 4.4% Thursday to $22.745 while copper fell 3% to $4.2750.
Euro zone
European shares closed higher today. The eurozone’s STOXX 600 gained 0.44%, the Spanish Ibex Index rose 1.14% and the German DAX 30 gained 0.23%. Meanwhile, the London’s FTSE 100 rose 0.16%, French CAC 40 climbed 0.59% and Italy’s FTSE MIB jumped 0.78%.
The Eurozone trade surplus shrank to EUR 20.7 billion in July from EUR 26.8 billion in the year-ago period, while passenger car registrations in the European Union dropped 19.1% year-over-year to 623 thousand units in August. Italy’s trade surplus narrowed to EUR 8.762 billion in July from EUR 9.689 billion in the year-ago month.
Economics
US initial jobless claims increased to 332 thousand in the week ending September 11 versus a reading of 312 thousand in the previous week.
The Philadelphia Fed manufacturing index climbed to 30.7 in September from 19.4 in August.
Retail sales increased 0.7% in August of 2021, following a revised 1.8% decline in July.
US business inventories rose 0.5% for July.
US natural-gas supplies surged 83 billion cubic feet last week, the Energy Information Administration said.
The Treasury International Capital report for July will be released at 4:00 p.m. ET.
Benzinga does not provide investment advice. All rights reserved.
Recommended Content
Editors’ Picks
EUR/USD holds below 1.0750 ahead of key US data
EUR/USD trades in a tight range below 1.0750 in the European session on Friday. The US Dollar struggles to gather strength ahead of key PCE Price Index data, the Fed's preferred gauge of inflation, and helps the pair hold its ground.
USD/JPY stays firm above 156.00 after BoJ Governor Ueda's comments
USD/JPY stays firm above 156.00 after surging above this level on the Bank of Japan's decision to leave the policy settings unchanged. BoJ Governor said weak Yen was not impacting prices but added that they will watch FX developments closely.
Gold price oscillates in a range as the focus remains glued to the US PCE Price Index
Gold price struggles to attract any meaningful buyers amid the emergence of fresh USD buying. Bets that the Fed will keep rates higher for longer amid sticky inflation help revive the USD demand.
Bitcoin Weekly Forecast: BTC’s next breakout could propel it to $80,000 Premium
Bitcoin’s recent price consolidation could be nearing its end as technical indicators and on-chain metrics suggest a potential upward breakout. However, this move would not be straightforward and could punish impatient investors.
US core PCE inflation set to signal firm price pressures as markets delay Federal Reserve rate cut bets
The core PCE Price Index, which excludes volatile food and energy prices, is seen as the more influential measure of inflation in terms of Fed positioning. The index is forecast to rise 0.3% on a monthly basis in March, matching February’s increase.